Teladoc Health, Inc. (TDOC) stock
TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3034% below fair value
$8.80+0.11 (+1.27%)
Close on Nov 13, 2026Market cap $1.60BP/E –Yield –
Teladoc Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Teladoc Health's ebitda for the twelve months ending Sep 30, 2023 was -$3.71B. For fiscal 2022 it was -$13.40B. The highest annual figure on record is -$5.12M in fiscal 2013.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$13.40B | – |
| FY2021 | Dec 31, 2021 | -$61.39M | – |
| FY2020 | Dec 31, 2020 | -$436.93M | – |
| FY2019 | Dec 31, 2019 | -$41.49M | – |
| FY2018 | Dec 31, 2018 | -$35.25M | – |
| FY2017 | Dec 31, 2017 | -$56.30M | – |
| FY2016 | Dec 31, 2016 | -$54.39M | – |
| FY2015 | Dec 31, 2015 | -$50.92M | – |
| FY2014 | Dec 31, 2014 | -$12.83M | – |
| FY2013 | Dec 31, 2013 | -$5.12M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | $29.58M | – |
| Q2 FY2023 | Jun 30, 2023 | $3.82M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.32M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.74B | -34401.0% |
| Q3 FY2022 | Sep 30, 2022 | -$9.72M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.04B | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.61B | – |
| Q4 FY2021 | Dec 31, 2021 | $10.90M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.67M | – |
| Q2 FY2021 | Jun 30, 2021 | -$27.61M | -1117.2% |
| Q1 FY2021 | Mar 31, 2021 | -$36.02M | – |
| Q4 FY2020 | Dec 31, 2020 | -$421.55M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.79M | – |
| Q2 FY2020 | Jun 30, 2020 | $2.71M | – |
| Q1 FY2020 | Mar 31, 2020 | -$11.30M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.70M | – |
| Q3 FY2019 | Sep 30, 2019 | -$10.33M | – |
| Q2 FY2019 | Jun 30, 2019 | -$12.18M | – |
| Q1 FY2019 | Mar 31, 2019 | -$11.32M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.28M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.03M | – |
| Q2 FY2018 | Jun 30, 2018 | -$10.10M | – |
| Q1 FY2018 | Mar 31, 2018 | -$10.84M | – |
| Q4 FY2017 | Dec 31, 2017 | -$17.16M | – |
| Q3 FY2017 | Sep 30, 2017 | -$15.12M | – |
| Q2 FY2017 | Jun 30, 2017 | -$11.82M | – |
| Q1 FY2017 | Mar 31, 2017 | -$12.20M | – |
| Q4 FY2016 | Dec 31, 2016 | -$10.63M | – |
See a number that looks wrong?